Samuel C. Blackman - Insider Trading & Ownership

Entity
Individual
Location
395 Oyster Point Blvd., Suite 217, South San Francisco, CA
Summary
The estimated net worth of Samuel C. Blackman is at least $36.1M dollars as of November 4, 2024. Samuel C. Blackman is the HEAD OF R&D of Day One Biopharmaceuticals, Inc. and owns shares of Day One Biopharmaceuticals, Inc. (DAWN) stock worth about $36.1M.
All Insider Reports
All Insider Reports

Ownership of Samuel C. Blackman

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
DAWN Day One Biopharmaceuticals, Inc. Head Of R&D $36.1M -$2.51M -6.5% Oct 31, 2024

Insider Transactions Reported by Samuel C. Blackman:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.